RESUMO
This review synthesizes examples of pharmacological agents who have off-target effects of an epigenetic nature. We expand upon the paradigm of epigenetics to include "quasi-epigenetic" mechanisms. Quasi-epigenetics includes mechanisms of drugs acting upstream of epigenetic machinery or may themselves impact transcription factor regulation on a more global scale. We explore these avenues with four examples of conventional pharmaceuticals and their unintended, but not necessarily adverse, biological effects. The quasi-epigenetic drugs identified in this review include the use of beta-lactam antibiotics to alter glutamate receptor activity and the action of cyclosporine on multiple transcription factors. In addition, we report on more canonical epigenome changes associated with pharmacological agents such as lithium impacting autophagy of aberrant proteins, and opioid drugs whose chronic use increases the expression of genes associated with addictive phenotypes. By expanding our appreciation of transcriptomic regulation and the effects these drugs have on the epigenome, it is possible to enhance therapeutic applications by exploiting off-target effects and even repurposing established pharmaceuticals. That is, exploration of "pharmacoepigenetic" mechanisms can expand the breadth of the useful activity of a drug beyond the traditional drug targets such as receptors and enzymes.
Assuntos
Analgésicos Opioides/farmacologia , Ciclosporina/farmacologia , Epigênese Genética , Regulação da Expressão Gênica/efeitos dos fármacos , Compostos de Lítio/farmacologia , beta-Lactamas/farmacologia , Sistema X-AG de Transporte de Aminoácidos/genética , Antibacterianos/farmacologia , Imunossupressores/farmacologia , Fármacos Neuroprotetores/farmacologia , Receptores Opioides/metabolismoRESUMO
Entamoeba histolytica is the causative agent of amoebic dysentery, a worldwide protozoal disease that results in approximately 100,000 deaths annually. The virulence of E. histolytica may be due to interactions with the host bacterial flora, whereby trophozoites engulf colonic bacteria as a nutrient source. The engulfment process depends on trophozoite recognition of bacterial epitopes that activate phagocytosis pathways. E. histolytica GPCR-1 (EhGPCR-1) was previously recognized as a putative G-protein-coupled receptor (GPCR) used by Entamoeba histolytica during phagocytosis. In the present study, we attempted to characterize EhGPCR-1 by using heterologous GPCR expression in Saccharomyces cerevisiae. We discovered that bacterial lipopolysaccharide (LPS) is an activator of EhGPCR-1 and that LPS stimulates EhGPCR-1 in a concentration-dependent manner. Additionally, we demonstrated that Entamoeba histolytica prefers to engulf bacteria with intact LPS and that this engulfment process is sensitive to suramin, which prevents the interactions of GPCRs and G-proteins. Thus, EhGPCR-1 is an LPS-recognizing GPCR that is a potential drug target for treatment of amoebiasis, especially considering the well-established drug targeting to GPCRs.
Assuntos
Entamoeba histolytica/metabolismo , Lipopolissacarídeos/farmacologia , Fagocitose , Proteínas de Protozoários/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Sequência de Aminoácidos , Entamoeba histolytica/efeitos dos fármacos , Entamoeba histolytica/microbiologia , Escherichia coli/patogenicidade , Dados de Sequência Molecular , Ligação Proteica , Proteínas de Protozoários/química , Receptores Acoplados a Proteínas G/química , Suramina/farmacologiaRESUMO
This minireview explores mitochondria as a site for antibiotic-host interactions that lead to pathophysiologic responses manifested as nonantibacterial side effects. Mitochondrion-based side effects are possibly related to the notion that these organelles are archaic bacterial ancestors or commandeered remnants that have co-evolved in eukaryotic cells; thus, this minireview focuses on mitochondrial damage that may be analogous to the antibacterial effects of the drugs. Special attention is devoted to aminoglycosides, chloramphenicol, and fluoroquinolones and their respective single side effects related to mitochondrial disturbances. Linezolid/oxazolidinone multisystemic toxicity is also discussed. Aminoglycosides and oxazolidinones are inhibitors of bacterial ribosomes, and some of their side effects appear to be based on direct inhibition of mitochondrial ribosomes. Chloramphenicol and fluoroquinolones target bacterial ribosomes and gyrases/topoisomerases, respectively, both of which are present in mitochondria. However, the side effects of chloramphenicol and the fluoroquinolones appear to be based on idiosyncratic damage to host mitochondria. Nonetheless, it appears that mitochondrion-associated side effects are a potential aspect of antibiotics whose targets are shared by prokaryotes and mitochondria-an important consideration for future drug design.
Assuntos
Antibacterianos/efeitos adversos , Mitocôndrias/efeitos dos fármacos , Ribossomos/efeitos dos fármacos , Acetamidas/efeitos adversos , Aminoglicosídeos/efeitos adversos , Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Cloranfenicol/efeitos adversos , Cloranfenicol/farmacologia , DNA Topoisomerases Tipo I/metabolismo , Fluoroquinolonas/efeitos adversos , Fluoroquinolonas/farmacologia , Humanos , Linezolida , Mitocôndrias/metabolismo , Oxazolidinonas/efeitos adversos , Oxazolidinonas/farmacologia , Biossíntese de ProteínasRESUMO
BACKGROUND: G protein-coupled receptors (GPCRs) constitute one of the largest groupings of eukaryotic proteins, and represent a particularly lucrative set of pharmaceutical targets. They play an important role in eukaryotic signal transduction and physiology, mediating cellular responses to a diverse range of extracellular stimuli. The phylum Platyhelminthes is of considerable medical and biological importance, housing major pathogens as well as established model organisms. The recent availability of genomic data for the human blood fluke Schistosoma mansoni and the model planarian Schmidtea mediterranea paves the way for the first comprehensive effort to identify and analyze GPCRs in this important phylum. RESULTS: Application of a novel transmembrane-oriented approach to receptor mining led to the discovery of 117 S. mansoni GPCRs, representing all of the major families; 105 Rhodopsin, 2 Glutamate, 3 Adhesion, 2 Secretin and 5 Frizzled. Similarly, 418 Rhodopsin, 9 Glutamate, 21 Adhesion, 1 Secretin and 11 Frizzled S. mediterranea receptors were identified. Among these, we report the identification of novel receptor groupings, including a large and highly-diverged Platyhelminth-specific Rhodopsin subfamily, a planarian-specific Adhesion-like family, and atypical Glutamate-like receptors. Phylogenetic analysis was carried out following extensive gene curation. Support vector machines (SVMs) were trained and used for ligand-based classification of full-length Rhodopsin GPCRs, complementing phylogenetic and homology-based classification. CONCLUSIONS: Genome-wide investigation of GPCRs in two platyhelminth genomes reveals an extensive and complex receptor signaling repertoire with many unique features. This work provides important sequence and functional leads for understanding basic flatworm receptor biology, and sheds light on a lucrative set of anthelmintic drug targets.
Assuntos
Planárias/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Schistosoma mansoni/metabolismo , AnimaisRESUMO
Recent studies identified strains of Salmonella that induce encephalopathies in calves exposed to stressful situations. In order to cause neurologic signs (such as ataxia, head tilt, and partial blindness), the strain must be able to cross the blood-brain barrier (BBB). One possible way is through the break down of tight junctions, which regulate the permeability of the BBB and can be weakened by enzymes such as collagenases. Salmonella and other Gram-negative bacteria contain a collagenase gene (clg) that is silenced in vitro but inducibly expressed in vivo. We hypothesized that the neuropathic strains of Salmonella express clg in response to neuroendocrine factors in the host and that the expressed collagenase perturbs the BBB allowing for CNS invasion by Salmonella. Our in vitro results revealed that clg is derepressed in serum obtained from stressed cattle. Derepression is relegated to the neuropathic Salmonella strains. In vivo studies indicated that clg expression is required for neuropathogenicity and that pharmacologic maintenance of the BBB prevents both the Salmonella invasion into the brain and the resulting neurologic signs. These studies identify a host-induced Salmonella collagenase that facilitates neuropathogenicity at the level of the BBB.
Assuntos
Barreira Hematoencefálica/metabolismo , Barreira Hematoencefálica/microbiologia , Doenças dos Bovinos/microbiologia , Colagenases/metabolismo , Interações Hospedeiro-Patógeno , Salmonelose Animal/microbiologia , Salmonella/enzimologia , Animais , Encéfalo/microbiologia , Bovinos , Doenças dos Bovinos/patologia , Perfilação da Expressão Gênica , Regulação Bacteriana da Expressão Gênica , Salmonella/patogenicidade , Salmonelose Animal/patologia , Soro/microbiologiaRESUMO
Terbinafine is an allylamine antifungal prescribed for the treatment of mycoses in humans. It is increasingly being used in veterinary patients. The purpose of this study was to evaluate the pharmacokinetic properties of terbinafine in dogs after a single oral dose. Ten healthy adult dogs were included in the study. A single dose of terbinafine (30-35 mg/kg) was administered orally, and blood samples were periodically collected over a 24 h period during which dogs were monitored for adverse effects. Two of 10 dogs developed transient ocular changes. A high-performance liquid chromatography assay was developed and used to determine plasma terbinafine concentrations. Pharmacokinetic analysis was performed using PK Solutions(®) computer software. Area under the curve (AUC) from time 0 to 24 h was 15.4 µg·h/mL (range 5-27), maximal plasma concentration (C(max) ) was 3.5 µg/mL (range 3-4.9 µg/mL) and time to C(max) (T(max) ) was 3.6 h (range 2-6 h). The time above minimal inhibitory concentration (T > MIC) as well as AUC/MIC was calculated for important invasive fungal pathogens and dermatophytes. The T > MIC was 17-18 h for Blastomyces dermatitidis, Histoplasma capsulatum and dermatophytes (Microsporum spp. and Trichophyton mentagrophytes), while the MIC for Sporothrix schenckii and Coccidioides immitis was exceeded for 9.5-11 h. The AUC/MIC values ranged from 9 to 13 µg h/mL for these fungi. Our results provide evidence supporting the use of terbinafine as an oral therapeutic agent for treating systemic and subcutaneous mycoses in dogs.
Assuntos
Antifúngicos/farmacocinética , Cães/sangue , Naftalenos/farmacocinética , Administração Oral , Animais , Antifúngicos/administração & dosagem , Antifúngicos/sangue , Cromatografia Líquida de Alta Pressão/veterinária , Esquema de Medicação/veterinária , Feminino , Masculino , Naftalenos/administração & dosagem , Naftalenos/sangue , TerbinafinaRESUMO
This study assessed the ability of Salmonella (572 isolates) to subsist on 12 different antibiotics. The majority (11/12) of the antibiotics enabled subsistence for at least 1 of 140 isolates. Furthermore, 40 isolates were able to subsist on more than one antibiotic. Antibiotic resistance and antibiotic subsistence do not appear to be equivalent.
Assuntos
Antibacterianos/metabolismo , Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Salmonella/efeitos dos fármacos , Salmonella/metabolismo , Meios de Cultura/química , Testes de Sensibilidade Microbiana , Viabilidade Microbiana , Salmonella/crescimento & desenvolvimento , Salmonella/isolamento & purificaçãoRESUMO
OBJECTIVE: To assess in pigs the pathogenicity and virulence of 3 strains of Salmonella spp capable of causing atypical salmonellosis in cattle. ANIMALS: 36 Holstein calves and 72 pigs experimentally infected with Salmonella spp. PROCEDURES: Representative Salmonella strains associated with 3 new disease phenotypes (protozoa-mediated hypervirulence, multisystemic cytopathicity, and encephalopathy) that have been characterized in cattle during the past 10 years were orally inoculated into pigs. Clinical manifestations were compared with those observed in cattle. Samples were collected from various tissues, and the presence of Salmonella organisms was assessed qualitatively and quantitatively by use of Salmonella-selective media. RESULTS: Of the 3 unique Salmonella disease phenotypes observed in cattle, only protozoa-mediated hypervirulence was observed in pigs. Hypervirulence was related to a more rapid onset of disease and higher pathogen burden in pigs than in cattle. This phenotype was observed in pigs inoculated with multiresistant Salmonella enterica serotypes Typhimurium or Choleraesuis bearing the Salmonella genomic island 1 (SGI1) integron. CONCLUSIONS AND CLINICAL RELEVANCE: Salmonella hypervirulence was identified in pigs noculated with SGI1-bearing strains exposed to free-living protozoa. Additionally, an SGI1-bearing strain of Salmonella Choleraesuis was detected that resulted in augmented virulence in pigs. Therefore, it appeared that protozoa-associated salmonellosis was analogous in pigs and cattle. Salmonella-mediated encephalopathy and multisystemic cytopathicity did not appear to be relevant diseases in pigs.
Assuntos
Doenças dos Bovinos/microbiologia , Salmonelose Animal/microbiologia , Salmonella/classificação , Salmonella/patogenicidade , Doenças dos Suínos/microbiologia , Animais , Bovinos , Feminino , Regulação Bacteriana da Expressão Gênica/fisiologia , Masculino , Salmonella/metabolismo , Suínos , VirulênciaRESUMO
The gastrointestinal (GI) tract microbiota is composed of complex communities. For all species examined thus far, culture and molecular analyses show that these communities are highly diverse and individuals harbor unique consortia. The objective of the current work was to examine inter-individual diversity of cattle fecal microbiota and determine whether Salmonella shedding status correlated with community richness or evenness parameters. Using a ribosomal gene array-based approach, oligonucleotide fingerprinting of ribosomal genes (OFRG), we analyzed 1440 16S genes from 19 fecal samples obtained from a cattle herd with a history of salmonellosis. Identified bacteria belonged to the phyla Firmicutes (53%), Bacteroidetes (17%), and Proteobacteria (17%). Sequence analysis of 16S rDNA gene clones revealed that Spirochaetes and Verrucomicrobia were also present in the feces. The majority of Firmicutes present in the feces belonged to the order Clostridiales, which was verified via dot blot analysis. beta-Proteobacteria represented 1.5% of the bacterial community as determined by real-time PCR. Statistical analysis of the 16S libraries from the 19 animals indicated very high levels of species richness and evenness, such that individual libraries represented unique populations. Finally, this study did not identify species that prevented Salmonella colonization or resulted from Salmonella colonization.
Assuntos
Doenças dos Bovinos/microbiologia , Fezes/microbiologia , RNA Ribossômico 16S/genética , Salmonelose Animal/microbiologia , Salmonella/genética , Animais , Sequência de Bases , Bovinos , Impressões Digitais de DNA/veterinária , DNA Bacteriano/química , DNA Bacteriano/genética , Doenças Endêmicas/veterinária , Feminino , Variação Genética , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Reação em Cadeia da Polimerase/veterinária , RNA Ribossômico 16S/química , Salmonella/classificação , Salmonella/isolamento & purificação , Salmonelose Animal/epidemiologia , Alinhamento de SequênciaRESUMO
OBJECTIVE: To determine whether an anti-Salmonella bacterium is involved in control of pathogen load in persistently infected cattle herds. ANIMALS: 24 Holstein calves experimentally infected and 39 Holstein cows naturally infected with Salmonella spp. PROCEDURES: An Escherichia coli (designated as P8E5) that possessed anti-Salmonella activity was isolated from Salmonella-negative bovine feces obtained from a herd with endemic Salmonella infection. In vitro analysis involved enumerating Salmonella enterica serovar Typhimurium coincubated with E coli P8E5. In vivo analysis involved coadministration of Salmonella spp and E coli P8E5 or an E coli control strain to neonatal Holstein calves. Fecal samples were collected on multiple days after inoculation, and quantitative PCR assay was performed by use of Salmonella-specific primers. RESULTS: E coli P8E5 reduced viability of Salmonella spp in vitro. Shedding of Salmonella organisms was diminished in calves administered E coli P8E5, whereas the control strain of E coli had no effect on shedding of Salmonella organisms. CONCLUSIONS AND CLINICAL RELEVANCE: In this study, an E coli strain was identified that possessed bacteriocin-like activity and was able to decrease viability of Salmonella organisms in vitro and in vivo. Therefore, it is possible that this organism could be representative of native microbiota that dampen Salmonella spp in persistently infected cattle herds.
Assuntos
Doenças dos Bovinos/microbiologia , Doenças dos Bovinos/terapia , Escherichia coli/crescimento & desenvolvimento , Enteropatias/veterinária , Salmonelose Animal/microbiologia , Salmonelose Animal/terapia , Salmonella typhimurium/crescimento & desenvolvimento , Animais , Animais Recém-Nascidos , Portador Sadio/microbiologia , Portador Sadio/veterinária , Bovinos , Doenças dos Bovinos/prevenção & controle , Contagem de Colônia Microbiana/veterinária , DNA Bacteriano/química , DNA Bacteriano/genética , Fezes/microbiologia , Feminino , Enteropatias/microbiologia , Enteropatias/prevenção & controle , Enteropatias/terapia , Reação em Cadeia da Polimerase/veterinária , Salmonelose Animal/prevenção & controleRESUMO
Prior studies revealed that yeast fermentation products, specifically XPC™ and related products (Diamond V, Cedar Rapids, IA), serve as viable food safety tools across multiple food animal species including cattle and poultry. Providing this supplement in feed leads to reduced prevalence, load, virulence, and antibiotic resistance of foodborne pathogens such as Salmonella and Escherichia coli O157:H7. These findings are worthy of further study, especially when coupled with the enhanced growth and performance observed with these products. Mechanistically, XPC appears to modulate these effects through the immune system and gut microbiome. Herein we further investigated this product and demonstrate that XPC mediates an enhancement of immunocyte killing of Salmonella in calves fed the product. Additionally, these studies reveal that XPC reduces the lymph node infiltration, invasiveness, and antibiotic resistance of Salmonella in dairy calves fed the product-consistent with findings observed in poultry and adult beef cattle. Furthermore, the reduction in invasiveness does not lead to a rebound hyperinvasive phenotype in Salmonella obtained from XPC-fed animals. In summary, these studies suggest that XPC reduces the invasion of Salmonella and may alter various phenotypic characteristics of the pathogen.
RESUMO
The objective of this study was to investigate an interaction between nematodes and gut Enterobacteriaceae that use benzimidazoles as a carbon source. By addressing this objective, we identified an anthelmintic resistance-like mechanism for gastrointestinal nematodes. We isolated 30 gut bacteria (family Enterobacteriaceae) that subsist on and putatively catabolize benzimidazole-class anthelmintics. C. elegans was protected from the effects of benzimidazoles when co-incubated with these Enterobacteriaceae that also protect adult ascarids from the effects of albendazole. This bacterial phenotype represents a novel mechanism by which gastrointestinal nematodes are potentially spared from the effects of benzimidazoles, without any apparent fitness cost to the parasite.
RESUMO
Tritrichomonas foetus is a sexually transmitted protozoan parasite that causes abortions in cattle and results in severe economic losses. In the United States, there are no safe and effective treatments for this parasite and infected animals are typically culled. In order to expedite drug discovery efforts, we investigated in vitro trophozoite killing assays amenable to high-throughput screening in 96 well plate formats. We evaluated the reduction of resorufin, incorporation of propidium iodide, and a luminescence-based ATP detection assay. Of these methods, reduction of resorufin was found to be the most reliable predictor of trophozoite concentrations. We further validated this method by conducting dose-response experiments suitable for calculation of EC50 values for two established compounds with known activity against trophozoites in vitro, namely, metronidazole and ronidazole. Our results demonstrate that the resorufin method is suitable for high-throughput screening and could be used to enhance efforts targeting new treatments for bovine trichomoniasis.
Assuntos
Anti-Helmínticos/farmacologia , Ensaios de Triagem em Larga Escala/veterinária , Medições Luminescentes/veterinária , Tritrichomonas foetus/efeitos dos fármacos , Trofozoítos/efeitos dos fármacos , Relação Dose-Resposta a Droga , Imagem ÓpticaRESUMO
Plazomicin is a next-generation aminoglycoside with a potentially unique set of clinical characteristics compared with other aminoglycosides. This study assessed the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of plazomicin against 15 clinical isolates as well as three reference strains representing Brucella abortus, Brucella melitensis and Brucella suis. These data were compared with those obtained for six other aminoglycosides and two aminocyclitols. Plazomicin and gentamicin were the only drugs demonstrating bactericidal activity towards two of the three Brucella spp., whilst plazomicin was the only drug exhibiting bactericidal activity against B. suis. This is the first study to assess the bactericidal nature of plazomicin against Brucella spp. in vitro.
Assuntos
Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Brucella abortus/efeitos dos fármacos , Brucella melitensis/efeitos dos fármacos , Brucella suis/efeitos dos fármacos , Viabilidade Microbiana/efeitos dos fármacos , Sisomicina/análogos & derivados , Brucella abortus/isolamento & purificação , Brucella melitensis/isolamento & purificação , Brucella suis/isolamento & purificação , Brucelose/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Sisomicina/farmacologiaRESUMO
Meningeal worms (Parelaphostrongylus tenuis) are a common malady of alpacas, often refractory to conventional treatments. Ivermectin is a very effective anthelmintic used against a variety of parasites but this drug is not consistently effective against alpaca meningeal worms once the parasite has gained access to the CNS, even if used in a protracted treatment protocol. Ivermectin is not effective against clinical cases of P. tenuis, raising the possibility that the drug is not sustained at therapeutic concentrations in the central nervous system (CNS). A specific protein (designated as p-glycoprotein (PGP)) effluxes ivermectin from the brain at the blood-brain barrier, thus hampering the maintenance of therapeutic concentrations of the drug in the CNS. Minocycline is a synthetic tetracycline antibiotic with an excellent safety profile in all animals tested to date. Minocycline has three unique characteristics that could be useful for treating meningeal worms in conjunction with ivermectin. First, minocycline is an inhibitor of PGP at the blood-brain barrier and this inhibition could maintain effective concentrations of ivermectin in the brain and meninges. Second, minocycline protects neurons in vivo through a number of different mechanisms and this neuroprotection could alleviate the potential untoward neurologic effects of meningeal worms. Third, minocycline is a highly lipid-soluble drug, thus facilitating efficient brain penetration. We thus hypothesized that minocycline will maintain ivermectin, or a related avermectin approved in ruminants (abamectin, doramectin, or eprinomectin), in the alpaca CNS. To test this hypothesis, we cloned the gene encoding the alpaca PGP, expressed the alpaca PGP in a heterologous expression system involving MDCK cells, and measured the ability of minocycline to inhibit the efflux of avermectins from the MDCK cells; doxycycline was used as a putative negative control (based on studies in other species). Our in vitro studies surprisingly revealed that doxycycline was effective at inhibiting the efflux of ivermectin and doramectin (minocycline had no effect). These two avermectins, in combination with doxycycline, should be considered when treating meningeal worms in alpacas.
Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/antagonistas & inibidores , Camelídeos Americanos/metabolismo , Doenças do Sistema Nervoso Central/veterinária , Doxiciclina/farmacologia , Interações Medicamentosas , Ivermectina/análogos & derivados , Sequência de Aminoácidos , Animais , Camelídeos Americanos/genética , Linhagem Celular , Doenças do Sistema Nervoso Central/tratamento farmacológico , Doenças do Sistema Nervoso Central/parasitologia , Cães , Regulação da Expressão Gênica/efeitos dos fármacos , Ivermectina/metabolismo , Ivermectina/farmacologia , Minociclina/farmacologia , Dados de Sequência MolecularRESUMO
This review considers available evidence for mechanisms of conferred adaptive advantages in the face of specific infectious diseases. In short, we explore a number of genetic conditions, which carry some benefits in adverse circumstances including exposure to infectious agents. The examples discussed are conditions known to result in resistance to a specific infectious disease, or have been proposed as being associated with resistance to various infectious diseases. These infectious disease-genetic disorder pairings include malaria and hemoglobinopathies, cholera and cystic fibrosis, tuberculosis and Tay-Sachs disease, mycotic abortions and phenylketonuria, infection by enveloped viruses and disorders of glycosylation, infection by filoviruses and Niemann-Pick C1 disease, as well as rabies and myasthenia gravis. We also discuss two genetic conditions that lead to infectious disease hypersusceptibility, although we did not cover the large number of immunologic defects leading to infectious disease hypersusceptibilities. Four of the resistance-associated pairings (malaria/hemogloginopathies, cholera/cystic fibrosis, tuberculosis/Tay-Sachs, and mycotic abortions/phenylketonuria) appear to be a result of selection pressures in geographic regions in which the specific infectious agent is endemic. The other pairings do not appear to be based on selection pressure and instead may be serendipitous. Nonetheless, research investigating these relationships may lead to treatment options for the aforementioned diseases by exploiting established mechanisms between genetically affected cells and infectious organisms. This may prove invaluable as a starting point for research in the case of diseases that currently have no reliably curative treatments, e.g., HIV, rabies, and Ebola.
RESUMO
Pathogenic Salmonella species initiate infection of a mammalian host by inducing their own uptake into intestinal M-cells. During the uptake process, the bacteria utilize an intrinsic secretion system to release proteins that enter host cells. The secreted invasion-mediating proteins subsequently interact with host cell components that induce alterations in the actin cytoskeleton. To identify potential cellular determinants of invasion, we employed a yeast two-hybrid system using the secreted Salmonella invasion protein (SipC) as the bait protein. This system identified cytokeratins, supportive components of the cytoskeletal matrix, as proteins that may physically interact with SipC. Transfection-based studies revealed an inhibition of Salmonella invasion when a dominant negative cytokeratin-18 was expressed. Immunofluorescent confocal microscopy studies revealed that Salmonella did not enter HEp-2 cells expressing the dominant negative cytokeratin-18. These results suggest that an interaction between SipC and cytokeratin-18 may occur as part of Salmonella invasion.
Assuntos
Proteínas de Bactérias/metabolismo , Células Eucarióticas/metabolismo , Queratinas/metabolismo , Infecções por Salmonella/microbiologia , Salmonella typhimurium/patogenicidade , Actinas/ultraestrutura , Sequência de Aminoácidos , Proteínas de Bactérias/genética , Sequência de Bases , Células Eucarióticas/microbiologia , Proteínas Fúngicas/metabolismo , Humanos , Queratinas/genética , Queratinas/ultraestrutura , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Microscopia Confocal , Dados de Sequência Molecular , Saccharomyces cerevisiae/metabolismo , Salmonella typhimurium/classificação , Salmonella typhimurium/fisiologia , Fatores de Transcrição/metabolismo , Transfecção , Células Tumorais Cultivadas , Virulência/fisiologiaRESUMO
Salmonellosis is an insidious and potentially epidemic problem in pre-weaned dairy calves. Managing this disease, or any other diarrheal disease, is a financial burden to producers. Calf mortalities and medicinal treatments are overt costs of salmonellosis, while hidden costs include hampered weight gains and persistent intestinal colonization of the pathogen. In this study, we examined the anti-Salmonella effects of Saccharomyces cerevisiae fermentation products (SCFP) incorporated into both the milk replacer and the starter grain. In a blinded study, 2-8 day-old calves were fed SCFP (n=20 calves) or an SCFP-free Control (n=20 calves) for two weeks before and three weeks after experimental challenge with Salmonella enterica serotype Typhimurium. Following the challenge, calves were monitored for clinical signs and parameters associated with salmonellosis. Calves were then euthanized and examined for rumen development and intestinal Salmonella colonization. When compared to calves that received milk replacer and feed lacking SCFP, calves fed SCFP had fewer bouts of diarrhea and fever. Rumens from these calves were more developed, as measured by the length of papillae, which is consistent with the enhanced weight gain observed in this treatment group. Additionally, Salmonella intestinal colonization was reduced in SCFP-fed calves and Salmonella fecal shedding disappeared at an earlier stage in these calves. This study revealed that the combination of two proprietary S. cerevisiae fermentation products provide marked benefit for preventing the negative effects of salmonellosis in pre-weaned dairy calves, while also boosting productivity. The mechanism of action needs to be clarified, but it may be related to the observed decrease in colonization by the pathogen and increase in rumen development.
Assuntos
Doenças dos Bovinos/dietoterapia , Diarreia/dietoterapia , Substitutos do Leite/administração & dosagem , Saccharomyces cerevisiae/química , Salmonelose Animal/dietoterapia , Ração Animal , Animais , Bovinos , Doenças dos Bovinos/microbiologia , Diarreia/microbiologia , Diarreia/veterinária , Fezes/microbiologia , Fermentação , Masculino , Rúmen/efeitos dos fármacos , Rúmen/crescimento & desenvolvimento , Rúmen/microbiologia , Saccharomyces cerevisiae/metabolismo , Salmonelose Animal/microbiologia , Salmonella enterica/patogenicidade , Salmonella enterica/fisiologia , Desmame , Aumento de PesoRESUMO
This manuscript considers available evidence that a specific Salmonella strain could be used as an effective orally-administered option for cancer therapy involving the brain. It has been established that Salmonella preferentially colonizes neoplastic tissue and thrives as a facultative anaerobe in the intra-tumor environment. Although Salmonella accumulates in tumors by passive processes, it is still possible for lipopolysaccharide to cause sepsis and endotoxic shock during the migration of bacteria to the tumor site. An LPS-free version of a recently identified Salmonella isolate may have the capability to circumvent the blood brain barrier and provide a safer method of reaching brain tumors. This isolate merits further research as a "Trojan horse" for future oral biotherapy of brain cancer.
Assuntos
Neoplasias Encefálicas/microbiologia , Salmonella/fisiologia , Animais , Antineoplásicos/administração & dosagem , Barreira Hematoencefálica , Encéfalo/patologia , Neoplasias Encefálicas/complicações , Neoplasias Encefálicas/terapia , Bovinos , Modelos Animais de Doenças , Humanos , Hipóxia , Lipopolissacarídeos/química , Mutação , Neoplasias/complicações , Neoplasias/microbiologia , Neoplasias/terapia , Sepse/fisiopatologia , Choque Séptico/fisiopatologia , SuínosRESUMO
OBJECTIVE: To assess antimicrobial resistance and transfer of virulence genes facilitated by subtherapeutic concentrations of antimicrobials in swine intestines. ANIMALS: 20 anesthetized pigs experimentally inoculated with donor and recipient bacteria. PROCEDURES: 4 recipient pathogenic bacteria (Salmonella enterica serotype Typhimurium, Yersinia enterocolitica, Shigella flexneri, or Proteus mirabilis) were incubated with donor bacteria in the presence of subinhibitory concentrations of 1 of 16 antimicrobials in isolated ligated intestinal loops in swine. Donor Escherichia coli contained transferrable antimicrobial resistance or virulence genes. After coincubations, intestinal contents were removed and assessed for pathogens that acquired new antimicrobial resistance or virulence genes following exposure to the subtherapeutic concentrations of antimicrobials. RESULTS: 3 antimicrobials (apramycin, lincomycin, and neomycin) enhanced transfer of an antimicrobial resistance plasmid from commensal E coli organisms to Yersinia and Proteus organisms, whereas 7 antimicrobials (florfenicol, hygromycin, penicillin G, roxarsone, sulfamethazine, tetracycline, and tylosin) exacerbated transfer of an integron (Salmonella genomic island 1) from Salmonella organisms to Yersinia organisms. Sulfamethazine induced the transfer of Salmonella pathogenicity island 1 from pathogenic to nonpathogenic Salmonella organisms. Six antimicrobials (bacitracin, carbadox, erythromycin, sulfathiazole, tiamulin, and virginiamycin) did not mediate any transfer events. Sulfamethazine was the only antimicrobial implicated in 2 types of transfer events. CONCLUSIONS AND CLINICAL RELEVANCE: 10 of 16 antimicrobials at subinhibitory or subtherapeutic concentrations augmented specific antimicrobial resistance or transfer of virulence genes into pathogenic bacteria in isolated intestinal loops in swine. Use of subtherapeutic antimicrobials in animal feed may be associated with unwanted collateral effects.